Linsidomine hydrochloride

• Description:

  Linsidomine hydrochloride (SIN-1 chloride) is considered as a metabolite of moxidomine, with vasodilation, inhibition of platelet aggregation, and antiangina activity. In myocardial ischemia-reperfusion models, Linsidomine hydrochloride to reduce myocardial necrosis and reperfusion induced endothelial dysfunction is associated with the cavernosal mechanism of action involved in nitric oxide release.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  206.63

• Molecular Formula:

  C6H11ClN4O2

• Notes:

  Research use only, not for human use.

• Receptor:

  Drug Metabolite

• CAS Number:

  16142-27-1